These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 28634071)
1. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization. Yoo G; Kim T; Chung C; Hwang DS; Lim DS Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Kim M; Kim T; Johnson RL; Lim DS Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714 [TBL] [Abstract][Full Text] [Related]
3. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
4. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
5. YAP/TAZ for cancer therapy: opportunities and challenges (review). Guo L; Teng L Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Jang JW; Kim MK; Bae SC Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552 [TBL] [Abstract][Full Text] [Related]
7. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation. Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141 [TBL] [Abstract][Full Text] [Related]
8. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
9. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399 [TBL] [Abstract][Full Text] [Related]
10. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949 [TBL] [Abstract][Full Text] [Related]
12. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634 [TBL] [Abstract][Full Text] [Related]
13. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review. Crawford JJ; Bronner SM; Zbieg JR Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112 [No Abstract] [Full Text] [Related]
14. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524 [TBL] [Abstract][Full Text] [Related]
15. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539 [TBL] [Abstract][Full Text] [Related]
17. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125 [TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762 [TBL] [Abstract][Full Text] [Related]
19. Arhgef7 promotes activation of the Hippo pathway core kinase Lats. Heidary Arash E; Song KM; Song S; Shiban A; Attisano L EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573 [TBL] [Abstract][Full Text] [Related]
20. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]